Blog Post

Healthcare and Life Sciences Blog
2 MIN READ

Intelligent App Chronicles: Azure API Management as an Enterprise API Gateway

ShellyAvery's avatar
ShellyAvery
Icon for Microsoft rankMicrosoft
Feb 12, 2024

The Intelligent App Chronicles for Healthcare is a webinar series designed to provide health and life sciences companies with a comprehensive guide to building intelligent healthcare applications.

 

The series will cover a wide range of topics including Azure Container Services, Azure AI Services, Azure Integration Services, and innovative solutions that can accelerate your Intelligent app journey. By attending these webinars, you will learn how to leverage the power of intelligent systems to build scalable and secure healthcare solutions that can transform the way you deliver care. Our hosts will be: (99+) Shelly (Finch) Avery | LinkedIn, (99+) Matthew Anderson | LinkedIn

 

This session happened in the past, see the recording here: 

Please join us for an informative session on how to use Azure API Management as an enterprise API gateway. You will discover how to use Azure API Management as an enterprise API gateway to create intelligent and secure healthcare applications.
Our speaker this week is Rob McKenna, Principal Technical Specialist for Azure Apps and Innovation, he will cover topics such as:
  • Benefits of a centralized and shared API gateway
  • Getting your enterprise teams started
  • Networking considerations for regulated industries
  • API availability for both internal and external API consumers
  • Improving API developer velocity via DevOps for API management and developer experience tooling.

 

Don’t miss this opportunity to learn from the experts and take your healthcare applications to the next level. Follow us for the Intelligent App Chronicles for Healthcare webinar series! https://aka.ms/AppSeries 

 

Thanks for reading!

Please follow the aka.ms/HLSBlog for all this great content. 

 

Thanks for reading, Shelly Avery | EmailLinkedIn  

Updated Mar 21, 2024
Version 6.0
No CommentsBe the first to comment